All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
APotentially durableStandard research/education caution
CMP-0053
Experimental

Fulipiftide / PEDF-derived 29-mer peptide

Regenerative / Tendon

Tendon regeneration, collagen organization, anti-inflammatory repair signaling

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
Peptide
Primary mechanism
PEDF-derived tendon stem/progenitor cell signaling
Primary market use
Tendon repair / dry eye

Pharmacology

Molecular weight (Da)
~3100
Oral bioavailability
N/A
Half-life
~2.5 hours
Route tags
SubQ; Injectable; route-dependent
Evidence level
Animal/Preclinical
Clinical status
Experimental
Value-for-money score
5 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Also described as PEDF 29-mer; durable tendon remodeling candidate

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend